Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This is an open-label, dose escalation and expansion, multi-center phase 2 study evaluating the safety and efficacy of SR-8541A administered orally in combination with intravenous botensilimab and balstilimab in subjects with MSS-CRC with and without active liver metastases.
Sponsor: Stingray Therapeutics
Check if you qualify for this colorectal cancer clinical trial in Houston, TX
If you're searching for colorectal cancer treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.